Metabolomics integrates high-throughput, high-resolution analytical techniques with bioinformatics to study metabolism and provide a unique perspective on organisms.
Genomics, transcriptomics, proteomics, and metabolomics detect and identify various molecules and study their functions at the DNA, mRNA, protein, and metabolite levels, respectively. Transcriptomics and proteomics are not yet able to fully express the full range of functions of an organism. Metabolomics quantifies the time-dependent multiplicity of metabolites produced by an organism's genetic modifications and by pathophysiological stimuli. The aim is to systematically elucidate the function of an organism by analyzing compounds at different developmental stages or in different growth environments and following their metabolic pathways with the aim of being able to map the full range of complex interactions between genes, proteins and metabolites.
Tumor and cancer is a complex disease in which multiple factors are involved causing disturbance of the functional balance of all systems of the body. Their metabolic effects are significantly different from those of normal tissues. The quantitative analysis of all small molecule metabolites in a given biological system by metabolomics at a given time and condition allows to quantify the overall situation of biological endogenous metabolites or to analyze the patterns that cause their endogenous and exogenous changes.
Different body fluids have different origins, distribution and functions, and therefore contain metabolite components that vary widely. Creative Proteomics provides metabolomics solutions for oncology research to accelerate the progress of relevant scientific research projects. Many biological tissues and fluids can be studied for metabolomics, including saliva, blood, urine, bile, emulsions, cerebrospinal fluid, and tissue extracts.
Metabolomics looks for tumor-specific metabolites from the dynamic metabolic pathways of the body and has good applications in all stages. In particular, it has significant advantages in disease pattern classification and pathological staging.
Monitoring changes in the transcriptional up- or down-regulation effects of oncogenes reveals the relationship between genes and phenotypes and provides new ideas for the study of tumor mechanisms.

Multiple analytical platforms, including GC-MS, LC-MS, UPLC-MS. Thousands of metabolites can be screened from a single biological sample, providing a comprehensive approach for probing disease mechanisms.
| Chromatography | Mass Spectrometry |
| GC (Q Exactive) (- mode MS) HPLC: HILIC (+/- mode MS) HPLC: RP C18 (+/-mode MS) IC (- mode MS) | Q Exactive MS Orbitrap Tribrid MS |
Creative Proteomics is a well-established partner in biopharmaceutical research and has extensive experience in metabolomics analysis. We provide solutions for oncology research in the direction of metabolomics analysis, accelerating the exploration of new horizons in science. If you want to know more, please contact us. Looking forward to cooperating with you.
Explore the future of metabolomics with Creative Proteomics. Discover cutting-edge solutions for metabolic analysis and research.
Copyright © 2026 Creative Proteomics. All rights reserved.